Surgery in addition to compression treatment could reduce the risk of recurrent leg ulcers

A UK study in this week's issue of THE LANCET highlights how surgery in addition to compression treatment could substantially reduce the risk of recurrent leg ulcers.

Venous leg ulceration affects 1-2% of people and accounts for 1% of health costs in developed countries. Treatment includes compression, leg raising, and exercise; no randomised trials have been done to investigate whether superficial surgery to remove part of the affected vein could be another treatment option.

Keith Poskitt from Cheltenham General Hospital, UK, and colleagues assessed the healing and recurrence rates after treatment with compression with or without surgery in people with leg ulceration. 500 patients were assessed by venous duplex imaging and were randomly allocated either compression treatment alone or in combination with superficial venous surgery.

The one-year recurrence rate was more than halved among Patients given surgery and compression compared with those given compression alone (12% compared with 28%, respectively). Healing rates were similar between the two groups.

Mr Poskitt comments: "Surgical correction of superficial venous reflux reduces 12-month ulcer recurrence. Most patients with chronic venous ulceration will benefit from the addition of simple venous surgery. This will result in reduced numbers of patients suffering with this chronic relapsing condition".

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover why typically normal protein drives prostate cancer